Sun Pharma hits over 5-yr high on hopes of robust revenue growth in Q2
newsdepo.com
Motilal Oswal Securities remains positive on Sun Pharma due to investments in the global Specialty portfolio improving overall profitabilitySun Pharma hits over 5-yr high on hopes of robust revenue growth in Q2
Motilal Oswal Securities remains positive on Sun Pharma due to investments in the global Specialty portfolio improving overall profitability Read more

